Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease

Pathology International
M KimuraH Nagura

Abstract

The distribution abnormality of vasoactive intestinal polypeptide-containing nerves (VIP-nerves) and substance P-containing nerves (SP-nerves) was immunohistochemically investigated in the colonic mucosa with inflammatory bowel disease (IBD) in relation to colonic glands and blood vessels in the lamina propria. In active ulcerative colitis (UC), VIP- and SP-nerves decreased in severe inflammatory lesions. VIP-nerves were almost absent particularly around crypt abscesses. Even in resolving and quiescent UC, VIP-nerves still decreased, depending on the decrease of glands and blood vessels. On the other hand, both nerves increased in some hypervascular lesions. In the uninvolved mucosa of UC, they did not change their distribution. In Crohn's disease, the distribution abnormality of both nerves resembled that of UC. These results suggest that the changes in VIP- and SP-nerve distributions in the mucosa with IBD are subsequent to mucosal inflammation and damage. However, these peptides are known to be immunoregulators, and their distribution abnormalities may induce the disorder of immunoregulation in the IBD mucosa and cause the mucosal damage and/or chronicity.

References

Jan 1, 1991·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·K FukushimaH Nagura
Apr 1, 1990·The Journal of Investigative Dermatology·W L MatisG F Murphy
Jan 1, 1991·Immunologic Research·H C ReineckerA Raedler
Sep 1, 1988·British Journal of Pharmacology·M A LowmanM K Church
Jun 1, 1989·The Journal of Experimental Medicine·L L LanierJ H Phillips
Aug 1, 1989·Digestive Diseases and Sciences·J CalamS R Bloom
Nov 1, 1989·Scandinavian Journal of Gastroenterology·S BjörckH Ahlman
Sep 1, 1968·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·P K Nakane
Oct 1, 1984·The Journal of Clinical Investigation·D G PayanE J Goetzl

❮ Previous
Next ❯

Citations

Mar 9, 2007·Inflammatory Bowel Diseases·Kara J Gross, Charalabos Pothoulakis
Apr 10, 2013·The Journal of Physiological Sciences : JPS·Takahiko ShiinaYasutake Shimizu
Jan 1, 1997·Pharmacology & Therapeutics·P Holzer, U Holzer-Petsche
Jun 8, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Robin C Spiller
Jun 9, 2000·Clinical and Experimental Immunology·B F QianA Danielsson
Jan 1, 1997·Mediators of Inflammation·J D van Bergeijk, J H Wilson
Jan 1, 1997·Inflammatory Bowel Diseases·M ReinshagenV E Eysselein
Oct 25, 2011·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Matthias A EngelPeter W Reeh
Aug 28, 2007·Pharmacology & Therapeutics·Anneke RijnierseAletta D Kraneveld
Dec 5, 2015·Frontiers in Immunology·Martina Di GiovangiulioGianluca Matteoli
May 1, 2007·Autonomic Neuroscience : Basic & Clinical·Lee BoyerKevan Jacobson
Mar 21, 2007·American Journal of Surgery·Christoph W MichalskiHelmut Friess
Dec 14, 2004·Journal of Neuroimmunology·Solveig Persson-SjögrenSture Forsgren
Apr 18, 2006·Autonomic Neuroscience : Basic & Clinical·Alessandro LecciCarlo Alberto Maggi
Apr 18, 2008·European Journal of Pharmacology·Aletta D KraneveldJohan Garssen
Jun 7, 2008·Autonomic Neuroscience : Basic & Clinical·Mariona AulíEster Fernández
Jul 6, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Francesca TavanoPierluigi di Sebastiano
Apr 3, 2004·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·F.T. Lundy, G.J. Linden
May 25, 2001·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·P VentoS Soinila
Jul 5, 2001·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J SchneiderM Schemann
Feb 13, 2001·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·I DepoortereT L Peeters
Mar 5, 2002·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M S Faussone-PellegriniJ Fioramonti
Aug 11, 1998·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M Miampamba, K A Sharkey
Nov 8, 2013·Polish Journal of Veterinary Sciences·M WdowiakA Kołodziejska-Sawerska
Aug 31, 2004·Journal of Cellular Physiology·Terence M O'ConnorFergus Shanahan
Feb 7, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·F AzpirozR C Spiller
Mar 28, 2006·Journal of Cellular and Molecular Medicine·Maria-Simonetta Faussone-Pellegrini
Oct 10, 2009·Current Opinion in Gastroenterology·Kara Gross Margolis, Michael David Gershon
Apr 1, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Edward S KimballPamela J Hornby
Sep 1, 2017·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·F SouffletM Neunlist
Aug 16, 2017·World Journal of Gastroenterology : WJG·Magdy El-SalhyJan Gunnar Hatlebakk
Dec 17, 2004·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·E S KimballP J Hornby
May 30, 2015·American Journal of Physiology. Gastrointestinal and Liver Physiology·Tamia K LapointeChristophe Altier
Aug 15, 2018·Journal of Molecular Neuroscience : MN·Catalina Abad, Yossan-Var Tan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.